Ideas to action: independent research for global prosperity
Research
Innovative, independent, peer-reviewed. Explore the latest economic research and policy proposals from CGD’s global development experts.
CGD NOTES
June 17, 2024
BRIEFS
June 17, 2024
WORKING PAPERS
June 10, 2024
WORKING PAPERS
June 12, 2024
All Research
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Research
BRIEFS
July 02, 2019
There have been impressive gains in global health over the past 20 years, with millions of lives saved through expanded access to essential medicines and other health products. But behind these successes is an unacceptable reality: in many low- and middle-income countries, lifesaving health products...
BRIEFS
July 02, 2019
To contribute to a growing base of knowledge and expertise on opportunities to reverse the specific effects of forest loss and degradation—and to improve the conditions of host populations and refugees in Cox’s Bazar—BRAC, the Center for Global Development, and The Nature...
REPORTS
June 24, 2019
Gavi’s mission—saving children’s lives and protecting people’s health by increasing equitable use of vaccines—remains highly relevant. Gavi 5.0 needs a new model to deliver on its laudable mission. This overview note lays out five challenges and summarizes some of ...
BRIEFS
May 23, 2019
The World Health Organization routinely develops and issues guidelines on how best to prevent, diagnose, and treat particular medical conditions. The guidelines are developed through a process determined by the WHO Guidelines Review Committee—a key part of which involves systematic evidence ap...
REPORTS
May 23, 2019
Internationally set goals and guidelines directly influ­ence the setting of health care priorities at the national level, affecting how limited resources are generated and allocated across health care needs. The Working Group on Incorporating Economics and Modelling in Global Health Goals and Gu...
REPORTS
May 09, 2019
The next global pandemic is a matter of when, not if. Preparing for this inevitability requires that policymakers understand not just the science of limiting disease transmission or engineering a drug, but also the practical challenges of expanding a response strategy to a regional or global level...